Sentence examples for using the new assay from inspiring English sources

Using the new assay, the IC50 value for a published inhibitor of S. agalactiae hyaluronidase, ascorbic acyl 6-palmitate, was 8.0 ± 1.0 μM.

Figure 2 Analytical data for DEQAS samples using the new assay.

B: Correlation between the 25OHD concentrations obtained using the new assay and the ALTM. Figure 4 Comparison of 25OHD concentration levels obtained using the new assay (blue) and ALTM (grey).

Using the new assay, we established a normal range of neutrophil directional migration speed values for healthy volunteers.

The offsets for ESR1 and HER2 were predetermined for this study by reassessment of the 167 samples from the previous study using the new assay conditions, resulting in the cutoffs of 19.5 for HER2 mRNA and 13.8 for ESR1 mRNA.

To resume and advance INA research, we developed a highly reproducible assay for determining the INA of plant tissues by revising conventional test tube nucleation assays and using the new assay, we surveyed plant tissues of over 600 species for INA (e.g. Sekozawa et al. 2002; Ueda et al. 2002; Ishikawa 2014).

Of particular relevance to the present study, we used the new assay to demonstrate the inhibitory effect of CaM on BRI1-mediated transphosphorylation activity.

The second was to determine whether urinary NGAL levels obtained using the new clinical assay could accurately predict AKI after cardiopulmonary bypass (CBP) in children.

113 patients (74 males and 39 females) were subjected to molecular analysis using the new commercial assay Myotonic Dystrophy SB kit, for detection of DM1 disease, including those in whom genetic test results were previously known from other laboratories using previous nonstandardized techniques.

They were subsequently confirmed at the Diabetes Research Institute Munich Laboratory (Munich, Germany) using the new, NIDDK standardized assay with standardized S-labeled GAD-65 or IA2-IC proteins, according to the harmonized NIDDK/NIH autoantibody methods.

Using the new NIH standardized assay, 9.8% (118 of 1,206) of youth with BMI ≥85th percentile and thought by pediatric endocrinologists to have type 2 diabetes were positive for GAD-65 and/or IA-2 antibodies.